Table 1 Baseline characteristics.
Patient characteristics | N = 33 |
|---|---|
Age (years), median (range) | 56 (range: 7–87) |
Sex, n (%) | |
Male | 15 (45.5) |
Female | 18 (54.5) |
Histology, n (%) | |
Alveolar soft part sarcoma | 10 (30.3) |
De-differentiated liposarcoma | 4 (12.1) |
Undifferentiated pleomorphic sarcoma | 3 (9.1) |
Undifferentiated sarcoma | 2 (6.1) |
Leiomyosarcoma | 2 (6.1) |
Clear cell sarcoma | 2 (6.1) |
Angiosarcoma | 2 (6.1) |
Inflammatory myofibroblastic tumour | 2 (6.1) |
Synovial sarcoma | 1 (3.3) |
Myofibroblastic sarcoma | 1 (3.3) |
Spindle cell sarcoma | 1 (3.3) |
Myxofibrosarcoma | 1 (3.3) |
Rhabdomyosarcoma | 1 (3.3) |
Malignant peripheral nerve sheath tumour | 1 (3.3) |
Primary tumour location, n (%) | |
Extremities | 16 (48.5) |
Peritoneal and retroperitoneal cavity | 12 (36.4) |
Visceral | 4 (12.1) |
Head | 1 (3.0) |
Surgical history, n (%) | |
Yes | 25 (75.8) |
No | 8 (24.2) |
Previous chemotherapy, n (%) | |
Yes | 15 (45.4) |
No | 18 (54.5) |
Previous radiotherapy, n (%) | |
Yes | 5 (15.2) |
No | 28 (84.8) |
Treatment lines of AIs plus ICIs, n (%) | |
First-line | 15 (45.5) |
Second-line and higher | 18 (54.5) |
